It is noted that DGKK was significantly correlated with overall survival time of NAFLD patients, which indicated that DGKK could be regarded as a potential prognostic marker molecule for NAFLD of HCC with cirrhosis patients. This evidence concerns the gene DGKK and metabolic dysfunction-associated steatotic liver disease.